Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Net Income towards Common Stockholders readings, the most recent being $63.7 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 12.33% to $63.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $214.6 million, a 14.19% increase, with the full-year FY2025 number at $207.6 million, up 34.4% from a year prior.
  • Net Income towards Common Stockholders hit $63.7 million in Q1 2026 for Catalyst Pharmaceuticals, up from $45.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $63.7 million in Q1 2026 to a low of -$30.8 million in Q3 2023.
  • Median Net Income towards Common Stockholders over the past 5 years was $37.8 million (2023), compared with a mean of $33.6 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: skyrocketed 267.96% in 2022 and later tumbled 235.24% in 2023.
  • Catalyst Pharmaceuticals' Net Income towards Common Stockholders stood at $34.3 million in 2022, then tumbled by 50.26% to $17.0 million in 2023, then soared by 172.8% to $46.5 million in 2024, then decreased by 1.18% to $45.9 million in 2025, then surged by 38.75% to $63.7 million in 2026.
  • The last three reported values for Net Income towards Common Stockholders were $63.7 million (Q1 2026), $45.9 million (Q4 2025), and $52.8 million (Q3 2025) per Business Quant data.